Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3874

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3874 9)

Label for Atorvastatin Calcium 80 mg film-coated tablets by NuCare Pharmaceuticals, Inc., showing a quantity of 90 tablets. The label includes the NDC number 68071-3874-9 and manufacturer information from Manora Pharma Pvt. Ltd., India. Warnings include keeping out of reach of children and storing at controlled temperatures (68-77°F).*

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Chemical structure diagram of atorvastatin calcium showing the molecular arrangement with calcium and water of crystallization components.*

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

A cumulative incidence line graph comparing Atorvastatin and Placebo over 3.5 years. The vertical axis represents cumulative incidence percentage, reaching up to 4%, while the horizontal axis shows time in years. Atorvastatin has a consistently lower incidence curve than Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005 indicating statistical significance.*

FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

A line graph showing cumulative hazard (%) over time (years) comparing placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage up to 15%. The graph compares placebo (dashed line) and atorvastatin (solid line) with a hazard ratio (HR) of 0.63 and p-value of 0.001 indicated on the chart.*

FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

A line graph showing the percentage of subjects experiencing the first major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg doses. The y-axis represents the percentage of subjects (%) experiencing the event, and the x-axis represents time in years. The graph compares event rates between the two dosage groups, with statistics indicating a hazard ratio of 0.78 and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.